Wealth Enhancement Trust Services’s Wave Life Sciences WVE Stock Holding History

Wealth Enhancement Trust Services’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.09K	Buy	+360	New	+$2.39K	﹤0.01%	994

Other funds holding WVE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Wealth Enhancement Trust Services's WVE Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Wave Life Sciences (WVE) in Q2 2026: 360 shares worth $2.09K. The stake represents ﹤0.01% of the portfolio and ranks #994 among its holdings.

136 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

Wealth Enhancement Trust Services held 360 shares of Wave Life Sciences worth $2.09K as of Q2 2026.
Wave Life Sciences was a new Wealth Enhancement Trust Services position in Q2 2026.
Wave Life Sciences made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #994 holding.
136 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.